
We evaluated the effects of the addition of escalating doses of tumor necrosis factor zzso to two fixed doses and schedules of a combination of zzso zzso and zzso zzso to determine the maximum tolerated dose of this zzso combination and its feasibility as an zzso zzso zzso patients with zzso cancer were zzso Each course consisted of 3 consecutive weeks of treatment with zzso 9 zzso zzso zzso zzso zzso or zzso zzso days 1, 3, and 5 each week for 3 weeks plus zzso continuous infusion 1 zzso zzso zzso zzso zzso or 3 zzso zzso zzso zzso zzso days zzso each week for 3 zzso zzso was administered only during the first week of each course zzso zzso for 2 h on days zzso The dose of zzso was escalated zzso 80, 120 zzso in zzso of 3 zzso The most common side effects were fever, zzso and fatigue in all zzso Grade zzso toxicity included anemia (3 zzso zzso (1 zzso zzso (2 zzso pulmonary zzso (3 zzso and weight loss (1 zzso Five patients withdrew from study due to zzso The combination of the three zzso is feasible as an zzso regimen in one of the following zzso zzso zzso 80 zzso as zzso infusion on days zzso + zzso 1 zzso zzso zzso continuous infusion on days zzso for 3 weeks + zzso 9 zzso zzso zzso zzso or zzso on days 1, 3, and 5 for 3 weeks, or zzso zzso 40 zzso as a zzso infusion on days zzso + zzso 3 zzso zzso zzso continuous infusion on days zzso for 3 weeks + zzso 9 zzso zzso zzso zzso or zzso on days 1, 3, and 5 for 3 zzso 

